MDS

>

CURE’s myelodysplastic syndrome (MDS) page is an extensive resource of cancer information featuring the latest myelodysplastic syndrome news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on MDS.

Latest News

Jane Biehl is a 12-year survivor of a very rare form of blood cancer, known as myelodysplastic syndrome (MDS). Catch up on all of Jane’s blogs here!
Taking Charge of My Care and Advocacy Following a Cancer Diagnosis

April 24th 2025

After a long battle with illness and seeking many specialists, I emphasize the need to self-advocate for ongoing care following my cancer diagnosis.

Illustration of blood cell.
Bexmarilimab Plus Vidaza Elicit Responses in Myelodysplastic Syndromes

April 16th 2025

Illustration of woman.
Sometimes Cancer is a (Welcome) Distraction

April 8th 2025

The EC has approved Rytelo in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome: © Crystal_Light - stock.adobe.com.
EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

March 25th 2025

Illustration of woman with blonde hair.
Looking For The Light After MDS

March 6th 2025

More News